CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Elevation Pharmaceuticals, Inc.

For profit

Also known as: Chief Medical Officer / Elevation Pharmaceuticals, Inc. | Elevation Oncology | Elevation Oncology, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 10, 2023

Acquired by Sunovion → Sumitomo Dainippon on Aug 30, 2012

Timeline

2000s

Jun 1, 2007
Elevation Pharmaceuticals, Inc.— Founded
Dec 1, 2009
Sumitomo Dainippon— Now

2010s

Aug 30, 2012
Sunovion— Acquired By

Drugs by trial phase (5 distinct, 3 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

eo-3021

Indications

Studied for

Recent trials (4)

NCT05980416Lead sponsorPhase 1Aug 10, 2023
NCT05980416OfficialPhase 1Aug 10, 2023
NCT04383210Lead sponsorPhase 2Jun 30, 2020
NCT01426009Study directorPhase 2Aug 1, 2011

Details

Founded: San Diego, CA, US Jun 1, 2007
Last known activity: Aug 10, 2023